跳至主要内容
临床试验/ACTRN12610000090011
ACTRN12610000090011尚未招募未知

utrigenomic risk profiles for Mild Cognitive Impairment, Alzheimer's disease and Parkinson's disease

Commonwealth Scientific and Industrial Research Organisation0 个研究点目标入组 900 人开始时间: 2010年1月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
55 Years 至 100 Years(—)
性别
All

入选标准

  • Control Group:
  • Male or female, Aged 55 and above, Not clinically diagnosed with mild cognitive impairment, Alzheimer's disease and Parkinson's, No family history of mild cognitive impairment, Alzheimer's disease and Parkinson's disease
  • Mild cognitive impairment Group:
  • Male or female, Aged 55 and above, Clinically diagnosed with mild cognitive impairment
  • Alzheimer's disease Group:
  • Male or female, Aged 55 and above, Clinically diagnosed with Alzheimer's disease
  • Parkinson's disease Group:
  • Male or female, Aged 55 or above, Clinically diagnosed with Parkinson's disease

排除标准

  • Control Group:
  • Patients who are undergoing chemotherapy,radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
  • Mild cognitive impairment Group:
  • Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
  • Alzheimer's disease Group:
  • Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
  • Parkinson's disease Group:
  • Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance

研究者

相似试验